Target intelligence / Profile preview

Pasteurella

Molecular classification
Gram-negative bacteria, Pathogen
01

Overview

Pasteurella is a genus of Gram-negative, facultatively anaerobic bacteria within the family Pasteurellaceae (NCBI, 2023). The most medically and veterinary significant member, Pasteurella multocida, is a commensal of the respiratory tract of many animals but functions as an opportunistic pathogen causing a variety of clinical syndromes, including hemorrhagic septicemia in cattle, fowl cholera in poultry, and atrophic rhinitis in swine (Wikipedia, 2023; Merck Veterinary Manual, 2022). In humans, Pasteurella is a frequent cause of zoonotic infections following animal bites or scratches, often manifesting as rapid-onset cellulitis or systemic infections in immunocompromised individuals (StatPearls, 2023). Because Pasteurella is a whole organism rather than a single molecular receptor, it contains multiple therapeutic targets for antimicrobial agents, such as the bacterial ribosome and cell wall synthesis enzymes (PubMed, 2021). Management of Pasteurella infections typically involves broad-spectrum antibiotics, though the emergence of resistance genes, often carried on plasmids, presents an ongoing challenge for treatment (Frontiers in Microbiology, 2020).

Other names
Pasteurella speciesPasteurellaceae
02

Mechanism of action

Antibiotics targeting Pasteurella typically inhibit bacterial cell wall synthesis (beta-lactams), inhibit protein synthesis by binding to the 30S or 50S ribosomal subunits (tetracyclines, macrolides, phenicols), or inhibit DNA replication by targeting DNA gyrase and topoisomerase IV (fluoroquinolones) (StatPearls, 2023; PubMed, 2021).

03

Biological functions

Bacterial pathogenesisToxin productionColonizationExtracellular polysaccharide capsule formation
04

Disease associations

PasteurellosisHemorrhagic septicemiaAtrophic rhinitisBovine respiratory diseaseWound infectionInfection
05

Safety considerations

Multidrug resistance (MDR)Zoonotic transmissionAllergic reactions to antimicrobial therapyDisruption of host microbiome
06

Interacting drugs

Penicillin

7 more in the full profile.

07

Biomarkers

Bacterial culture16S rRNA sequencingPCR for kmt geneSerotyping (e.g., Carter's types A, B, D, E, F)

Beyond the preview

Go deeper on Pasteurella.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pasteurella.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call